<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2025-067</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-9103</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДРУГИЕ ПРОБЛЕМЫ ЭНДОКРИНОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OTHER PROBLEMS OF ENDOCRINOLOGY</subject></subj-group></article-categories><title-group><article-title>Оценка эффективности опросника AMS для скрининга дефицита тестостерона у мужчин с анкилозирующим спондилитом</article-title><trans-title-group xml:lang="en"><trans-title>Evaluation of the effectiveness of the AMS questionnaire for screening hypogonadism in men with ankylosing spondylitis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5290-156X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Паневин</surname><given-names>Т. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Panevin</surname><given-names>T. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Паневин Тарас Сергеевич, к.м.н., научный сотрудник; доцент кафедры факультетской и поликлинической терапии с курсом эндокринологии</p><p>115522, Россия, Москва, Каширское шоссе, д. 34А</p><p>680000, Россия, Хабаровск, ул. Муравьева-Амурского, д. 35 </p></bio><bio xml:lang="en"><p>Taras S. Panevin, Cand. Sci. (Med.), Researcher; Associate Professor of the Department of Faculty and Polyclinic Therapy with a Course in Endocrinology</p><p>34А, Kashirskoe Shosse, Moscow, 115522, Russia</p><p>35, Muravyov-Amursky St., Khabarovsk, 680000, Russia</p></bio><email xlink:type="simple">tarasel@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3195-5187</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Эрдес</surname><given-names>Ш. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Erdes</surname><given-names>Sh. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Эрдес Шандор Федорович, д.м.н., ведущий научный сотрудник</p><p>115522, Россия, Москва, Каширское шоссе, д. 34А </p></bio><bio xml:lang="en"><p>Shandor F. Erdes, Dr. Sci. (Med.), Leading Researcher</p><p>34А, Kashirskoe Shosse, Moscow, 115522, Russia </p></bio><email xlink:type="simple">123456_57@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4579-2836</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зоткин</surname><given-names>Е. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Zotkin</surname><given-names>E. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зоткин Евгений Германович, д.м.н., первый заместитель директора</p><p>115522, Россия, Москва, Каширское шоссе, д. 34А </p></bio><bio xml:lang="en"><p>Evgeniy G. Zotkin, Dr. Sci. (Med.), First Deputy Director</p><p>34А, Kashirskoe Shosse, Moscow, 115522, Russia</p></bio><email xlink:type="simple">ezotkin@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4285-0869</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глухова</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Glukhova</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Глухова Светлана Ивановна, к.ф.-м.н., старший научный сотрудник</p><p>115522, Россия, Москва, Каширское шоссе, д. 34А </p></bio><bio xml:lang="en"><p>Svetlana I. Glukhova, Cand. Sci. (Phys.-Math.), Senior Researcher</p><p>34А, Kashirskoe Shosse, Moscow, 115522, Russia</p></bio><email xlink:type="simple">sveglukhova@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6476-4294</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Салянова</surname><given-names>Е. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Salyanova</surname><given-names>E. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Салянова Екатерина Петровна, к.м.н., заведующая лабораторией иммунодиагностики</p><p>115522, Россия, Москва, Каширское шоссе, д. 34А </p></bio><bio xml:lang="en"><p>Ekaterina P. Salyanova, Cand. Sci. (Med.), Head of the Laboratory of Immunodiagnostics</p><p>34А, Kashirskoe Shosse, Moscow, 115522, Russia</p></bio><email xlink:type="simple">tdk180@rambler.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7501-9185</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Самаркина</surname><given-names>Е. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Samarkina</surname><given-names>E. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Самаркина Елена Юрьевна, младший научный сотрудник</p><p>115522, Россия, Москва, Каширское шоссе, д. 34А </p></bio><bio xml:lang="en"><p>Elena Yu. Samarkina, Junior Researcher</p><p>34А, Kashirskoe Shosse, Moscow, 115522, Russia</p></bio><email xlink:type="simple">samarkinale@list.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научно-исследовательский институт ревматологии имени В.А. Насоновой;&#13;
Дальневосточный государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Nasonova Research Institute of Rheumatology;&#13;
Far Eastern State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Научно-исследовательский институт ревматологии имени В.А. Насоновой</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>24</day><month>05</month><year>2025</year></pub-date><volume>0</volume><issue>6</issue><fpage>100</fpage><lpage>106</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Паневин Т.С., Эрдес Ш.Ф., Зоткин Е.Г., Глухова С.И., Салянова Е.П., Самаркина Е.Ю., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Паневин Т.С., Эрдес Ш.Ф., Зоткин Е.Г., Глухова С.И., Салянова Е.П., Самаркина Е.Ю.</copyright-holder><copyright-holder xml:lang="en">Panevin T.S., Erdes S.F., Zotkin E.G., Glukhova S.I., Salyanova E.P., Samarkina E.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/9103">https://www.med-sovet.pro/jour/article/view/9103</self-uri><abstract><p>Введение. В связи с тем, что значительная часть пациентов с анкилозирующим спондилитом (АС) – мужчины, актуальной проблемой является изучение репродуктивного здоровья, в частности клинической диагностики синдрома гипогонадизма.Цель. Оценить чувствительность и специфичность опросника возрастных симптомов мужчины (Aging Males Symptoms – AMS) для диагностики гипогонадизма среди пациентов с АС.Материалы и методы. В одномоментное сплошное исследование включено 82 мужчины с АС, находившихся на стационарном лечении в ФГБНУ НИИР им. В.А. Насоновой. Пациентам выполнено определение уровня общего тестостерона с последующим разделением на подгруппы с нормальным (≥12,0 нмоль/л) и сниженным его уровнем. Для скрининга клинических признаков дефицита тестостерона все исследуемые мужчины заполняли опросник AMS. Был выполнен корреляционный анализ между баллами AMS с уровнем тестостерона и клинико-лабораторными показателями АС. Проведен ROC-анализ чувствительности и специфичности опросника AMS в сравнении с лабораторной диагностикой гипогонадизма у пациентов данной выборки.Результаты. Симптомы андрогенодефицита по результатам проведенного анкетирования заподозрены у 87,8%. Гипогонадизм (снижение уровня тестостерона менее 12,0 нмоль/л) выявлен у 13,4% пациентов. Выявлено полное отсутствие значимых корреляционных связей между уровнем тестостерона и общим баллом, а также отдельными компонентами опросника AMS. Выявлены значимые положительные связи (преимущественно по общему баллу и соматическим вопросам) с индексами активности BASDAI и ASDAS, положительные корреляционные связи между отдельными компонентами опросника AMS и уровнями С-реактивного белка и СОЭ. Сексуальная составляющая опросника AMS имела значимую положительную корреляционную связь со стажем и стадией АС, функциональным классом, а также всеми позвоночными индексами. При проведении ROC-анализа площадь под ROC-кривой составила 0,558 (95% ДИ 0,386–0,729; p = 0,54).Выводы. Опросник AMS показал низкую чувствительность и специфичность для диагностики симптомов андрогенодефицита у мужчин с АС, что может быть обусловлено значимым вкладом в его результаты активности и функциональных нарушений АС.</p></abstract><trans-abstract xml:lang="en"><p>Introduction. Due to the fact that a significant proportion of patients with ankylosing spondylitis (AS) are men, the study of reproductive health, in particular the clinical diagnosis of hypogonadism syndrome, is a pressing issue.Aim. To evaluate the sensitivity and specificity of the Aging Male Symptoms (AMS) questionnaire for diagnosing hypogonadism in patients with AS.Materials and methods. A cross-sectional continuous study included 82 men with AS who were undergoing inpatient treatment at the V.A. Nasonova Research Institute of Rheumatology. The patients underwent determination of their total testosterone levels and subsequent division into subgroups with normal (≥12.0 nmol/l) and reduced levels. All men completed the AMS questionnaire to screen for clinical signs of testosterone deficiency. A correlation analysis was performed between the AMS scores with testosterone levels and clinical and laboratory parameters of AS. ROC analysis of the sensitivity and specificity of the AMS questionnaire was performed in comparison with laboratory diagnostics of hypogonadism in patients of this sample.Results. Based on the results of the questionnaire, androgen deficiency symptoms were suspected in 87.8%. Hypogonadism (testosterone level decreased to less than 12.0 nmol/l) was detected in 13.4% of patients. There was a complete absence of significant correlations between the testosterone level and the total score, as well as individual components of the AMS questionnaire. There were significant positive correlations (mainly for the total score and somatic questions) with the BASDAI and ASDAS activity indices, positive correlations between individual components of the AMS questionnaire and the levels of C-reactive protein and ESR. The sexual component of the AMS questionnaire had a significant positive correlation with the duration and stage of AS, functional class, and all vertebral indices. When conducting the ROC analysis, the area under the ROC curve was 0.558 (95% CI 0.386–0.729; p = 0.54).Conclusion. The AMS questionnaire showed low sensitivity and specificity for diagnosing androgen deficiency symptoms in men with AS, which may be due to the significant contribution of AS activity and functional disorders to its results.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>анкилозирующий спондилит</kwd><kwd>тестостерон</kwd><kwd>гипогонадизм</kwd><kwd>андрогенодефицит</kwd><kwd>AMS</kwd><kwd>опросник</kwd><kwd>иммуновоспаление</kwd><kwd>репродуктивное здоровье</kwd></kwd-group><kwd-group xml:lang="en"><kwd>ankylosing spondylitis</kwd><kwd>testosterone</kwd><kwd>hypogonadism</kwd><kwd>androgen deficiency</kwd><kwd>AMS</kwd><kwd>questionnaire</kwd><kwd>immunoinflammation</kwd><kwd>reproductive health</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена в рамках государственного задания по теме «Эволюция аксиальных спондилоартритов на основе комплексного динамического изучения молекулярно-биологических, молекулярно-генетических, клинико-визуализационных факторов прогрессирования заболевания, качества жизни, коморбидности и таргетной инновационной терапии» №125020501435-8.</funding-statement><funding-statement xml:lang="en">The work was performed as part of state assignment on axial spondyloarthritis evolution assessed by comprehensive longitudinal analysis of molecular biological, molecular genetic, clinical and visualization factors for disease progression, quality of life, comorbidity and targeted innovative therapy No. 125020501435-8.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Эрдес ШФ, Ребров АП, Дубинина ТВ, Бадокин ВВ, Бочкова АГ, Бугрова ОВ и др. Спондилоартриты: современная терминология и определения. Терапевтический архив. 2019;91(5):84–88. https://doi.org/10.26442/00403660.2019.05.000208.</mixed-citation><mixed-citation xml:lang="en">Erdes ShF, Rebrov AP, Dubinina TV, Badokin VV, Bochkova AG, Bugrova OV et al. Spondyloarthritis: modern terminology and definitions. Terapevticheskii Arkhiv. 2019;91(5):84–88. (In Russ.) https://doi.org/10.26442/00403660.2019.05.000208.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Румянцева ДГ, Дубинина ТВ, Демина АБ, Смирнов АВ, Эрдес Ш. Сравнительный анализ основных клинических проявлений у мужчин и женщин с ранним аксиальным спондилоартритом. Научно-практическая ревматология. 2019;55(4):440–444. Режим доступа: https://rsp.mediar-press.net/rsp/article/view/2757.</mixed-citation><mixed-citation xml:lang="en">Rumyantseva DG, Dubinina TV, Demina AB, Smirnov AV, Erdes Sh. Comparative analysis of main clinical manifestations in males and females with early axial spondyloarthritis. Rheumatology Science and Practice. 2019;57(4):440–444. (In Russ.) Available at: https://rsp.mediar-press.net/rsp/article/view/2757.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Perez-Garcia LF, Te Winkel B, Carrizales JP, Bramer W, Vorstenbosch S, van Puijenbroek E et al. Sexual function and reproduction can be impaired in men with rheumatic diseases: A systematic review. Semin Arthritis Rheum. 2020;50(3):557–573. https://doi.org/10.1016/j.semarthrit.2020.02.002.</mixed-citation><mixed-citation xml:lang="en">Perez-Garcia LF, Te Winkel B, Carrizales JP, Bramer W, Vorstenbosch S, van Puijenbroek E et al. Sexual function and reproduction can be impaired in men with rheumatic diseases: A systematic review. Semin Arthritis Rheum. 2020;50(3):557–573. https://doi.org/10.1016/j.semarthrit.2020.02.002.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Паневин ТС, Роживанов РВ, Зоткин ЕГ, Авдеева АС, Глухова СИ. Синдром гипогонадизма у мужчин при воспалительных заболеваниях суставов: частота и клинические особенности. Терапевтический архив. 2024;96(5):486–493. https://doi.org/10.26442/00403660.2024.05.202704.</mixed-citation><mixed-citation xml:lang="en">Panevin TS, Rozhivanov RV, Zotkin EG, Avdeeva AS, Glukhova SI. Hypogonadism in men with inflammatory joint diseases: Frequency and clinical characteristics. Terapevticheskii Arkhiv. 2024;96(5):486–493. (In Russ.) https://doi.org/10.26442/00403660.2024.05.202704.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Дедов ИИ, Мокрышева НГ, Мельниченко ГА, Роживанов РВ, Камалов АА, Мкртумян АМ и др. Проект клинических рекомендаций «Синдром гипогонадизма у мужчин». Ожирение и метаболизм. 2021;18(4):496–507. https://doi.org/10.14341/omet12817.</mixed-citation><mixed-citation xml:lang="en">Dedov II, Mokrysheva NG, Melnichenko GA, Rozhivanov RV, Kamalov AA, Mkrtumyan AM et al. Draft of Russian clinical practice guidelines “Male hypogonadism”. Obesity and Metabolism. 2021;18(4):496–507. (In Russ.) https://doi.org/10.14341/omet12817.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng JB, Liang QF, Li JH, Zhan SC, Yu XH, Zhao J et al. Longitudinal Trends of AMS and IIEF-5 Scores in Randomly-Selected Community Men 40 to 80 Years Old: Preliminary Results. J Sex Med. 2019;16(10):1567–1573. https://doi.org/10.1016/j.jsxm.2019.07.017.</mixed-citation><mixed-citation xml:lang="en">Zheng JB, Liang QF, Li JH, Zhan SC, Yu XH, Zhao J et al. Longitudinal Trends of AMS and IIEF-5 Scores in Randomly-Selected Community Men 40 to 80 Years Old: Preliminary Results. J Sex Med. 2019;16(10):1567–1573. https://doi.org/10.1016/j.jsxm.2019.07.017.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Heinemann LA, Saad F, Zimmermann T, Novak A, Myon E, Badia X et al. The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions. Health Qual Life Outcomes. 2003;1:15. https://doi.org/10.1186/1477-7525-1-15.</mixed-citation><mixed-citation xml:lang="en">Heinemann LA, Saad F, Zimmermann T, Novak A, Myon E, Badia X et al. The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions. Health Qual Life Outcomes. 2003;1:15. https://doi.org/10.1186/1477-7525-1-15.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Baillargeon J, Al Snih S, Raji MA, Urban RJ, Sharma G, Sheffield-Moore M et al. Hypogonadism and the risk of rheumatic autoimmune disease. Clin Rheumatol. 2016;35(12):2983–2987. https://doi.org/10.1007/s10067-016-3330-x.</mixed-citation><mixed-citation xml:lang="en">Baillargeon J, Al Snih S, Raji MA, Urban RJ, Sharma G, Sheffield-Moore M et al. Hypogonadism and the risk of rheumatic autoimmune disease. Clin Rheumatol. 2016;35(12):2983–2987. https://doi.org/10.1007/s10067-016-3330-x.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab. 2004;89(7):3313–3318. https://doi.org/10.1210/jc.2003-031069.</mixed-citation><mixed-citation xml:lang="en">Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab. 2004;89(7):3313–3318. https://doi.org/10.1210/jc.2003-031069.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Zarotsky V, Huang MY, Carman W, Morgentaler A, Singhal PK, Coffin D, Jones TH. Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men. Andrology. 2014;2(6):819–834. https://doi.org/10.1111/andr.274.</mixed-citation><mixed-citation xml:lang="en">Zarotsky V, Huang MY, Carman W, Morgentaler A, Singhal PK, Coffin D, Jones TH. Systematic literature review of the risk factors, comorbidities, and consequences of hypogonadism in men. Andrology. 2014;2(6):819–834. https://doi.org/10.1111/andr.274.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Moore C, Huebler D, Zimmermann T, Heinemann LA, Saad F, Thai DM. The Aging Males’ Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol.2004;46(1):80–87. https://doi.org/0.1016/j.eururo.2004.01.009.</mixed-citation><mixed-citation xml:lang="en">Moore C, Huebler D, Zimmermann T, Heinemann LA, Saad F, Thai DM. The Aging Males’ Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol.2004;46(1):80–87. https://doi.org/0.1016/j.eururo.2004.01.009.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Morley JE, Perry HM 3rd, Kevorkian RT, Patrick P. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas. 2006;53(4):424–429. https://doi.org/10.1016/j.maturitas.2005.07.004.</mixed-citation><mixed-citation xml:lang="en">Morley JE, Perry HM 3rd, Kevorkian RT, Patrick P. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas. 2006;53(4):424–429. https://doi.org/10.1016/j.maturitas.2005.07.004.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Conway K, Heinemann LA, Giroudet C, Johannes EJ, Myon E, Taieb C, Raynaud JP. Harmonized French version of the Aging Males’ Symptoms Scale. Aging Male. 2003;6(2):106–109. https://doi.org/10.1080/tam.6.2.106.109.</mixed-citation><mixed-citation xml:lang="en">Conway K, Heinemann LA, Giroudet C, Johannes EJ, Myon E, Taieb C, Raynaud JP. Harmonized French version of the Aging Males’ Symptoms Scale. Aging Male. 2003;6(2):106–109. https://doi.org/10.1080/tam.6.2.106.109.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rosen RC, Araujo AB, Connor MK, Elstad EA, McGraw SA, Guay AT et al. Assessing symptoms of hypogonadism by self-administered questionnaire: qualitative findings in patients and controls. Aging Male. 2009;12(2-3):77–85. https://doi.org/10.1080/13685530903184043.</mixed-citation><mixed-citation xml:lang="en">Rosen RC, Araujo AB, Connor MK, Elstad EA, McGraw SA, Guay AT et al. Assessing symptoms of hypogonadism by self-administered questionnaire: qualitative findings in patients and controls. Aging Male. 2009;12(2-3):77–85. https://doi.org/10.1080/13685530903184043.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kang J 2nd, Ham BK, Oh MM, Kim JJ, Moon du G. Correlation between serum total testosterone and the AMS and IIEF questionnaires in patients with erectile dysfunction with testosterone deficiency syndrome. Korean J Urol. 2011;52(6):416–420. https://doi.org/10.4111/kju.2011.52.6.416.</mixed-citation><mixed-citation xml:lang="en">Kang J 2nd, Ham BK, Oh MM, Kim JJ, Moon du G. Correlation between serum total testosterone and the AMS and IIEF questionnaires in patients with erectile dysfunction with testosterone deficiency syndrome. Korean J Urol. 2011;52(6):416–420. https://doi.org/10.4111/kju.2011.52.6.416.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Clapauch R, Braga DJ, Marinheiro LP, Buksman S, Schrank Y. Risk of late-onset hypogonadism (andropause) in Brazilian men over 50 years of age with osteoporosis: usefulness of screening questionnaires. Arq Bras Endocrinol Metabol. 2008;52(9):1439–1447. https://doi.org/10.1590/s0004-27302008000900006.</mixed-citation><mixed-citation xml:lang="en">Clapauch R, Braga DJ, Marinheiro LP, Buksman S, Schrank Y. Risk of late-onset hypogonadism (andropause) in Brazilian men over 50 years of age with osteoporosis: usefulness of screening questionnaires. Arq Bras Endocrinol Metabol. 2008;52(9):1439–1447. https://doi.org/10.1590/s0004-27302008000900006.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Basar MM, Aydin G, Mert HC, Keles I, Caglayan O, Orkun S, Batislam E. Relationship between serum sex steroids and Aging Male Symptoms score and International Index of Erectile Function. Urology. 2005;66(3):597–601. https://doi.org/10.1016/j.urology.2005.03.060.</mixed-citation><mixed-citation xml:lang="en">Basar MM, Aydin G, Mert HC, Keles I, Caglayan O, Orkun S, Batislam E. Relationship between serum sex steroids and Aging Male Symptoms score and International Index of Erectile Function. Urology. 2005;66(3):597–601. https://doi.org/10.1016/j.urology.2005.03.060.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Nisihara R, Heil Junior LJ, Fagundes FG, Sobreiro B, Campos APB, Simioni J, Skare TL. Erectile Dysfunction, Testosterone Levels and Disease Activity in Ankylosing Spondylitis Patients. Urology. 2021;153:210–214. https://doi.org/10.1016/j.urology.2021.01.008.</mixed-citation><mixed-citation xml:lang="en">Nisihara R, Heil Junior LJ, Fagundes FG, Sobreiro B, Campos APB, Simioni J, Skare TL. Erectile Dysfunction, Testosterone Levels and Disease Activity in Ankylosing Spondylitis Patients. Urology. 2021;153:210–214. https://doi.org/10.1016/j.urology.2021.01.008.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Berg KH, Rohde GE, Prøven A, Benestad EEP, Østensen M, Haugeberg G. Sexual Quality of Life in Patients with Axial Spondyloarthritis in the Biologic Treatment Era. J Rheumatol. 2019;46(9):1075–1083. https://doi.org/10.3899/jrheum.180413.</mixed-citation><mixed-citation xml:lang="en">Berg KH, Rohde GE, Prøven A, Benestad EEP, Østensen M, Haugeberg G. Sexual Quality of Life in Patients with Axial Spondyloarthritis in the Biologic Treatment Era. J Rheumatol. 2019;46(9):1075–1083. https://doi.org/10.3899/jrheum.180413.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
